Diego Basile Colugnati

Diego Basile Colugnati

Auto-generated profile, based on publicly available information

Diego Basile Colugnati

Department of Physiological Sciences, Institute of Biological Sciences, Universidade Federal de Goiás, Goiânia, Brazil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2013 in Clinical Science
Verified
Journal Article
Closed access
PDF file
ÁSÁlvaro P. S. Souza
Álvaro P. S. Souza
DSDeny B. S. Sobrinho
Deny B. S. Sobrinho
JAJônathas F. Q. Almeida
Jônathas F. Q. Almeida
GAGisele M. M. Alves
Gisele M. M. Alves
LMLarissa M. Macedo
Larissa M. Macedo
CCCarlos H. Castro
Carlos H. Castro
The aim of the present study was to investigate the coronary effects of Ang-(1–7) [angiotensin-(1–7)] in hypertrophic rat hearts. Heart hypertrophy was induced by abdominal aorta CoA (coarctation). Ang-(1–7) and AVE 0991, a non-peptide Mas-receptor agonist, at picomolar concentration, induced a significant vasodilation in hearts from sham-operated rats. These effects were blocked by the Mas receptor antagonist A-779. Pre-treatment with L-NAME (NG-nitro-L-arginine methyl ester) or ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinozalin-1-one) [NOS (NO synthase) and soluble guanylate cyclase inhibitors respectively] also abolished the effect of Ang-(1–7) in control hearts. The coronary vasodilation produced by Ang-(1–7) and AVE 0991 was completely blunted in hypertrophic hearts. Chronic oral administration of losartan in CoA rats restored the coronary vasodilation effect of Ang-(1–7). This effect was blocked by A-779 and AT2 receptor (angiotensin II type 2 receptor) antagonist PD123319. Acute pre-incubation with losartan also restored the Ang-(1–7)-induced, but not BK (bradykinin)-induced, coronary vasodilation in hypertrophic hearts. This effect was inhibited by A-779, PD123319 and L-NAME. Chronic treatment with losartan did not change the protein expression of Mas and AT2 receptor and ACE (angiotensin-converting enzyme) and ACE2 in coronary arteries from CoA rats, but induced a slight increase in AT2 receptor in aorta of these animals. Ang-(1–7)-induced relaxation in aortas from sham-operated rats was absent in aortas from CoA rats. In vitro pre-treatment with losartan restored the Ang-(1–7)-induced relaxation in aortic rings of CoA rats, which was blocked by the Mas antagonist A-779 and L-NAME. These data demonstrate that Mas is strongly involved in coronary vasodilation and that AT1 receptor (angiotensin II type 1 receptor) blockade potentiates the vasodilatory effects of Ang-(1–7) in the coronary beds of pressure-overloaded rat hearts through NO-related AT2- and Mas-receptor-dependent mechanisms. These data suggest the association of Ang-(1–7) and AT1 receptor antagonists as a potential therapeutic avenue for coronary artery diseases.

1 June 2008 in Clinics
Verified
Journal Article
Open access
PDF file
FSFulvio A. Scorza
Fulvio A. Scorza
DCDiego B. Colugnati
Diego B. Colugnati
APAline P. Pansani
Aline P. Pansani
ESEliza Y.F. Sonoda
Eliza Y.F. Sonoda
RARICARDO Mario ARIDA
RICARDO Mario ARIDA
ECEsper A. Cavalheiro
Esper A. Cavalheiro
Approximately 1% of the population has epilepsy, the most common neurological disorder. Moreover, people with epilepsy are more likely to die prematurely than those without epilepsy, and the most common epilepsy-related category of death is sudden unexpected death in epilepsy (SUDEP). Information concerning risk factors for SUDEP is conflicting, but potential risk factors include: age, early onset of epilepsy, duration of epilepsy, uncontrolled seizures, seizure frequency, number of antiepileptic drugs and winter temperatures. Additionally, the cause of SUDEP is still unknown; however, the most commonly suggested mechanisms are cardiac abnormalities during and between seizures. This review discusses the epidemiology, risk factors, etiology, and preventative measures in the management of SUDEP.

10 September 2019 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
ABAmanda S. M. Bessa
Amanda S. M. Bessa
ÉJÉrika F. Jesus
Érika F. Jesus
ANAllancer D. C. Nunes
Allancer D. C. Nunes
CPCarolina N. R. Pontes
Carolina N. R. Pontes
ILIsmaley S. Lacerda
Ismaley S. Lacerda
CCCarlos Henrique Castro
Carlos Henrique Castro

1 December 2005 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
PRPauline Rangel
Pauline Rangel
RCRoberta Monterazzo Cysneiros
Roberta Monterazzo Cysneiros
RARICARDO Mario ARIDA
RICARDO Mario ARIDA
MAMarly de Albuquerque
Marly de Albuquerque
DCDiego Basile Colugnati
Diego Basile Colugnati
FSFulvio Alexandre Scorza
Fulvio Alexandre Scorza
OBJECTIVE: To further characterize the capacity of lovastatin to prevent hippocampal neuronal loss after pilocarpine-induced status epilepticus (SE) METHOD: Adult male Wistar rats were divided into four groups: (A) control rats, received neither pilocarpine nor lovastatin (n=5); (B) control rats, received just lovastatin (n=5); (C) rats that received just pilocarpine (n=5); (D) rats that received pilocarpine and lovastatin (n=5). After pilocarpine injection (350mg/kg, i.p.), only rats that displayed continuous, convulsive seizure activity were included in our study. Seizure activity was monitored behaviorally and terminated with an injection of diazepam (10 mg/kg, i.p.) after 4 h of convulsive SE. The rats treated with lovastatin received two doses of 20mg/kg via an oesophagic probe immediately and 24 hours after SE induction. Seven days after pilocarpine-induced SE, all the animals were perfused and their brains were processed for histological analysis through Nissl method. RESULTS: The cell counts in the Nissl-stained sections performed within the hippocampal formation showed a significant cell loss in rats that received pilocarpine and presented SE (CA1= 26.8 ± 13.67; CA3= 38.1 ± 7.2; hilus= 43.8 ± 3.95) when compared with control group animals (Group A: CA1= 53.2 ± 9.63; CA3= 63.5 ± 13.35; hilus= 59.08 ± 10.24; Group B: CA1= 74.3 ± 8.16; CA3= 70.1 ± 3.83; hilus= 70.6 ± 5.10). The average neuronal cell number of CA1 subfield of rats that present SE and received lovastatin (44.4 ± 17.88) was statically significant increased when compared with animals that just presented SE. CONCLUSION: Lovastatin exert a neuroprotective role in the attenuation of brain damage after SE.

28 March 2016 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
APAline P. Pansani
Aline P. Pansani
DCDiego B. Colugnati
Diego B. Colugnati
CSCarla Scorza
Carla Scorza
AAAntonio-Carlos G. de Almeida
Antonio-Carlos G. de Almeida
ECEsper A. Cavalheiro
Esper A. Cavalheiro
FSFulvio A. Scorza
Fulvio A. Scorza
Sudden and unexpected death in epilepsy (SUDEP) is the most common type of death among patients with epilepsy. Here, we address the importance of the experimental models in search of the mechanisms...

1 June 2016 in Life Sciences
Verified
Journal Article
Closed access
LMLarissa Matuda Macedo
Larissa Matuda Macedo
ÁSÁlvaro Paulo da Silva Souza
Álvaro Paulo da Silva Souza
MMMarilda Luz de Andrade De Maria
Marilda Luz de Andrade De Maria
CBClayton Luiz Borges
Clayton Luiz Borges
CSCélia Maria de Almeida Soares
Célia Maria de Almeida Soares
CCCarlos Henrique Castro
Carlos Henrique Castro